Amalgamated Bank’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,470
| Closed | -$21K | – | 2563 |
|
|
2025
Q4 | $21K | Sell |
1,470
-119
| -7% | -$1.48K | ﹤0.01% | 2094 |
|
|
2025
Q3 | $15K | Hold |
1,589
| – | – | ﹤0.01% | 2276 |
|
|
2025
Q2 | $13K | Hold |
1,589
| – | – | ﹤0.01% | 2329 |
|
|
2025
Q1 | $11K | Buy |
1,589
+230
| +17% | +$1.71K | ﹤0.01% | 2338 |
|
|
2024
Q4 | $11K | Sell |
1,359
-11,897
| -90% | -$112K | ﹤0.01% | 2399 |
|
|
2024
Q3 | $139K | Sell |
13,256
-357
| -3% | -$4.35K | ﹤0.01% | 1646 |
|
|
2024
Q2 | $159K | Buy |
13,613
+1,227
| +10% | +$19.1K | ﹤0.01% | 1628 |
|
|
2024
Q1 | $261K | Sell |
12,386
-2,198
| -15% | -$39.1K | ﹤0.01% | 1527 |
|
|
2023
Q4 | $262K | Sell |
14,584
-1,975
| -12% | -$34.8K | ﹤0.01% | 1713 |
|
|
2023
Q3 | $273K | Buy |
16,559
+1,133
| +7% | +$20.5K | ﹤0.01% | 1668 |
|
|
2023
Q2 | $308K | Sell |
15,426
-537
| -3% | -$10.3K | ﹤0.01% | 1664 |
|
|
2023
Q1 | $302K | Sell |
15,963
-1,340
| -8% | -$29.7K | ﹤0.01% | 1643 |
|
|
2022
Q4 | $392K | Hold |
17,303
| – | – | ﹤0.01% | 1579 |
|
|
2022
Q3 | $457K | Buy |
17,303
+7
| +0% | +$208 | ﹤0.01% | 1477 |
|
|
2022
Q2 | $427K | Sell |
17,296
-558
| -3% | -$13.9K | ﹤0.01% | 1531 |
|
|
2022
Q1 | $593K | Sell |
17,854
-1,022
| -5% | -$28.4K | ﹤0.01% | 1473 |
|
|
2021
Q4 | $617K | Sell |
18,876
-263
| -1% | -$8.96K | ﹤0.01% | 1484 |
|
|
2021
Q3 | $802K | Buy |
19,139
+314
| +2% | +$11.3K | 0.01% | 1361 |
|
|
2021
Q2 | $731K | Buy |
+18,825
| New | +$673K | 0.01% | 1438 |
|
|
2021
Q1 | – | Sell |
-5,585
| Closed | -$253K | – | 1619 |
|
|
2020
Q4 | $253K | Buy |
+5,585
| New | +$195K | 0.01% | 1322 |
|
|
2020
Q3 | – | Sell |
-5,727
| Closed | -$211K | – | 1512 |
|
|
2020
Q2 | $211K | Sell |
5,727
-492
| -8% | -$18.3K | 0.01% | 1274 |
|
|
2020
Q1 | $201K | Sell |
6,219
-217
| -3% | -$9.04K | ﹤0.01% | 1365 |
|
|
2019
Q4 | $264K | Buy |
6,436
+254
| +4% | +$10K | ﹤0.01% | 1485 |
|
|
2019
Q3 | $220K | Sell |
6,182
-66
| -1% | -$2.67K | ﹤0.01% | 1500 |
|
|
2019
Q2 | $321K | Buy |
6,248
+1,117
| +22% | +$55.8K | 0.01% | 1321 |
|
|
2019
Q1 | $294K | Buy |
5,131
+165
| +3% | +$8.17K | 0.01% | 1277 |
|
|
2018
Q4 | $208K | Buy |
+4,966
| New | +$291K | 0.01% | 1392 |
|
|
2018
Q3 | – | Sell |
-4,622
| Closed | -$332K | – | 1590 |
|
|
2018
Q2 | $332K | Buy |
+4,622
| New | +$221K | 0.01% | 1258 |
|
Other funds holding RGNX
RG
VCM
IHAM
Amalgamated Bank's RGNX Position: Q1 2026 in Review
Amalgamated Bank sold out of Regenxbio (RGNX) in Q1 2026, closing a stake of 1,470 shares — an estimated $21K sold.
Amalgamated Bank first reported a position in RGNX in Q2 2018 and held it in 28 quarters. The position peaked at $802K in Q3 2021. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.
- Amalgamated Bank reported no remaining Regenxbio position as of Q1 2026 after selling out during the quarter.
- Amalgamated Bank sold 1,470 Regenxbio shares in Q1 2026, an estimated $21K.
- Amalgamated Bank first reported a position in Regenxbio in Q2 2018 and held it in 28 quarters.
- Amalgamated Bank's Regenxbio position peaked at $802K in Q3 2021.
- 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.
Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.